Literature DB >> 20166431

Effect of phytomedicines, AM-1, niprisan and nifadin on the pharmacokinetics of chloroquine in rats.

K B Mustapha1, M T Bakare-Odunola, M Garba, O O Obodozie, I S Enemali, U S Inyan.   

Abstract

The single oral dose pharmacokinetics of chloroquine was studied alone and after coadministration with phytomedicines NIPRID\92\001\1-1 (AM-1), Niprisan, and Nifadin in rats. Plasma chloroquine concentrations were measured using High performance liquid chromatography (HPLC) method developed earlier in our laboratory. The data were fitted into a WinNonlin standard non-compartmental programme. The co-administration of the herbal medicines with chloroquine produced decrease in the serum concentration of chloroquine at each sampling time. The highest decrease of 85% occurring at the time of peak concentration (1 h) was recorded with Nifadin, followed by 75% with Niprisan the least was 50% with AM-1. Significant reduction was also observed in some other parameters, such as area under the serum concentration- time curve (AUC(0-24)) and maximum serum concentration (Cmax) while the apparent volume of distribution (Vd) and elimination half-life (t 1/2beta) increased significantly (P< 0.05). It was concluded that the gastric presence of the herbal medicines significantly impaired the absorption of chloroquine in rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20166431     DOI: 10.1007/BF03191166

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  The effect of garlic supplements on the pharmacokinetics of saquinavir.

Authors:  Stephen C Piscitelli; Aaron H Burstein; Nada Welden; Keith D Gallicano; Judith Falloon
Journal:  Clin Infect Dis       Date:  2001-12-05       Impact factor: 9.079

2.  In vivo approach to determine the route of optimal drug absorption in rats.

Authors:  O Lhote; A Decoodt; A Moulin; A Dufour
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991       Impact factor: 2.441

3.  The disposition of chloroquine and its main metabolite desethylchloroquine in volunteers with and without chloroquine-induced pruritus: evidence for decreased chloroquine metabolism in volunteers with pruritus.

Authors:  O G Ademowo; O Sodeinde; O Walker
Journal:  Clin Pharmacol Ther       Date:  2000-03       Impact factor: 6.875

4.  Chloroquine-resistant falciparum malaria from Africa.

Authors:  B H Kean
Journal:  JAMA       Date:  1979-01-26       Impact factor: 56.272

5.  Letter: Quinine and chloroquine antagonism in falciparum malaria.

Authors:  A P Hall
Journal:  Trans R Soc Trop Med Hyg       Date:  1973       Impact factor: 2.184

6.  Antimalarial drug resistance and combination chemotherapy.

Authors:  N White
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

7.  Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.

Authors:  K S Lown; D G Bailey; R J Fontana; S K Janardan; C H Adair; L A Fortlage; M B Brown; W Guo; P B Watkins
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

Review 8.  The public health impact of chloroquine resistance in Africa.

Authors:  J F Trape
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

Review 9.  Grapefruit juice-drug interactions.

Authors:  D G Bailey; J Malcolm; O Arnold; J D Spence
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

10.  Interaction between chloroquine sulphate and aqueous extract of Azadirachta indica A. Juss (Meliaceae) in rabbits.

Authors:  Sunday Vitalis Nwafor; Peter Achunike Akah; Charles Obgonnaya Okoli; Adaoma Chinaemerem Onyirioha; Chukwuemeka Sylvesta Nworu
Journal:  Acta Pharm       Date:  2003-12       Impact factor: 2.230

  10 in total
  1 in total

1.  Effect of NIPRISAN® on CYP3A4 activity in vitro.

Authors:  Bulus Adzu; Collen Masimirembwa; Kudirat Bola Mustapha; Roslyn Thelingwani; Rukaiyatu Abdullahi Kirim; Karniyus Shingu Gamaniel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-01-24       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.